In the Gothenburg cohort, this ratio was significantly higher in AD individuals with an APOE ε4/ε4 genotype compared with APOE ε3/ε3 and ε3/ε4, while in the Barcelona cohort, the ratios were at a similar level among AD individuals with different APOE genotypes. The gene discussed is APOE; the disease is Alzheimer disease.